Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Professional Development > Part 25 > Flashcards

Part 25 Flashcards

1
Q

Wernicke’s aphasia

A

Classically localized to lesions affecting the posterior superior temporal gyrus, markedly impaired comprehension where speech is voluminous but meaningless often described as a word salad, usually speech retains normal cadence and intonation and patient apepars completely unaware of deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Wernicke-Korsakoff syndrome

A

Associated with alcoholism, but can occur in other situations such as malnutrition or dialysis, classic triad is hoemorrhagic necrosis in midline brain structure producing deficits in mentaiton (encephalopathy), oculomotor function, and gait ataxia, administer thiamine as soon as expected as untreated results in death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anterograde amnesia

A

The impaired ability to formulate new memories

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Retrograde amnesia

A

Loss of all memories prior to an event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Delirium

A

Acute change (hours to days) where a patient has fluctuating levels of consciousness easily confused with psychiatric disorders most often due to primary underlying causes such as a medical condition, medication or drug withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Delirium diagnosis (4)

A
  • NOT mini mental status exam
  • confusion survey
  • electrolytes, creatinine, tox screen, drug levels, etc (rule out)
  • neuroimaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common medical etiologies of delirium (6)

A
  • infection
  • fluid and electrolyte disturbance
  • withdrawal
  • toxicity
  • metabolic disturbances
  • post op states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sundowning

A

Distinguished condition from delirium, frequently seen poorly understood phenomenon with frequent recurrence*** characterized by change in mental status and behavior often becoming more agitated as the day ends

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dementia vs delirium

A

Insidious vs acute, stable and progressive vs fluctuating, sensorium intact till late vs impaired, poor short term memory vs globally impaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When I say amyloid plaques and neurofibrilary tangles you say…

A

….alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pick’s disease/frontotemporal dementia

A

dementia is initially manifested by changes in personality and social behavior or language progressing over time to a more global dementia, progresses more rapidly than alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dementia with lewy bodies

A

form of dementia is characterized by the presence of abnormal aggregates of protein that develop inside nerve cells. These are identified under the microscope when histology is performed on the brain, distinctive clinical features including visual hallucinations, parkinsonism, cognitive fluctuations, and dysautonomia, differentiated from parkinson disease because cognitive decline is manifested much earlier than motor symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vascular dementia

A

Result of brain ischemia, no understood risk factors and not fully understood, no uniform diagnostic criteria, also referred to as post stroke dementia as clinical features are consistent with vascular etiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Parkinson disease dementia

A

Characterized by executive function (early findings include brady and akinesia, rigidity, etc) and sees memory loss as a later finding, most with parkinson disease will go on to develop this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sarcopenia

A

Decline in lean body mass often associated with age and a corresponding increase in total body fat that occurs in up to 50% of the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Leading causes of involuntary weight loss in the elderly (3)

A
  • depression
  • cancer
  • benign GI disease such as dysphagia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cachexia

A

Inflammatory metabolic disorder with excess muscle loss and prostoglandin production throughout the body due to underlying condition, relatively rapid and giving characteristic emaciated appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oral/dental health problems that affect the elderly (3)

A
  • dental caries
  • periodontal disease
  • xerostomia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vit A nutrition deficiencies side effects in elderly (3)

A
  • dry skin
  • bitots spots
  • xeropthalmia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vit B6 nutrition deficiencies side effects in elderly (3)

A
  • glossitis
  • peripheral neuropathy
  • anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Elder abuse

A

Mistreatment for individuals generally greater than or equal to 60 years including abuse, neglect, or financial exploitation, perpetrated by those in an ONGOING relationship that involves expectation of responsibility toward a victim** (excludes abuse by strangers, has to be a caretaker of some form - doctor, taxi driver, family), can be physical (including neglect even self neglect), sexual, or psychological (majority)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Decisional capacity

A

The ability to communicate a choice, understand relevant info, appreciate the situation and its consequences, and reason about treatment options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Executive capacity

A

The ability to execute ones decisions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Self neglect

A

Failure of vulnerable elder to provide for own care and protection (also called failure to thrive), excludes elderly who have capacity but choose not to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

PE findings that indicate elder abuse (8)

A
  • traumatic alopecia (hair pulled)
  • SPIRAL FRACTURE in long bone***
  • abrasions or skin tears
  • burns
  • lacerations
  • evidence of restraint
  • pressure ulcer
  • pain or soreness in genital area or new onset STI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Mandatory elderly abuse reporting

A

-Ethical responsibility for provider to care for patients and document and report concern for elder misreatment, if suspected in a facility call the long term care ombudsman, if in the general population call adult protective services.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Secretion of insulin is triggered by these 5 things

A
  • glucose
  • amino acids
  • fatty acids
  • ketone bodies
  • Epi/norepi
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Absence of insulin transfers us from a ___ state to a ___ state

A

anabolic, catabolic (in absence of insulin we see glycogen converted to glucose, gluconeogenesis, and decreased cellular uptake of glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Therapeutic uses of insulin (3)

A
  • diabetes mellitus (type 1 all patients and some type 2)
  • IV for diabetic ketoacidosis
  • treatment of hyperkalemia (pulls K+ intracellularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Recombinant human insulin analogs

A

Bioidentical insulin grown in e coli or yeast that has been slightly modified to have a different time course (either shorter or longer acting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Rapid acting insulin analog time frame compared to regular

A

5-30 minutes, 30-60 (but have a shorter duration of action in 3-5 hours, are more convenient because can be administered with or just before a meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Metformin (glucophage) function

A

-Drug of choice for initial treatment of type 2 diabetes, when not A1C goal reached can use additional agents depending on comorbidities (SGL2 inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

If max dose of 2 drugs insufficient to achieve glycemic control, then…

A

….insulin or another drug can be added

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Principal differences between first and 2nd gen sulfonylureas

A

Second gen are much more potent at lower doses and serious interactions are less common and are therefore widely used and generally superior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

3 second gen sulfonylureas

A
  • Glipizide (glucotrol)
  • glyburide
  • glimepiride
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Sulfonylureas mech of action

A

Stimulate release of insulin from pancreatic tissues by binding receptor sites on B cell causing depolarization triggering increase in intracelular calcium and thus insulin release (pancreas must be able to produce insulin for them to be effective, with prolonged use agents enhance cellular sensitivity to insulin thru unknown mechanism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Sulfonylureas ADR’s (4)

A
  • Hypoglycemia (tell patients not to skip meals)
  • weight gain 5-10 pounds
  • hematologic reactions such as lekupenia or thrombocytopenia
  • disulfuram like reaction (flushing, palpitations, nausea reported with use when drinking on chlorpropamide ( a gen 1 agent)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Metformin mech of action

A
  • lowers blood glucose primarily thru decreasing hepatic gluconeogenesis and secretion of glucagon like peptide
  • does not stimulate insulin release from pancreas and does not actively drive down blood glucose levels posing little to any added risk of hypoglycemia when used alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Metformin therapeutic use (4)

A
  • monotherapy in patients whose blood sugar levels are not controlled by diet or exercise alone
  • combo therapy with other antidiabetic agents such as sulfonylureas
  • PCOS off labeled use
  • Cardiovascular reduction in risk of MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Metformin ADR’s (3)

A
  • GI effects
  • Decreased B12 and folic acid absorption which can lead to deficiencies (not recommended to supplement with metformin)
  • Lactic acidosis in patients with low GFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Acarbose (precose) drug class and mech of action

A
  • alpha glucosidase inhibitor
  • oral agent that reversibly inhibits alpha glucosidase, and enzyme present in brush border mucosa of small intestine, slows rate at which complex polysaccharides and sucrose are digested resulting in lower postprandial blood glucose conc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Acarbose (precose) ADR (1)

A

-GI effects due to fermentation of unabsorbed carbohydrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Miglitol (glyset) function

A

Delays carb conversion of oligosaccharides and complex carbs to glucose decreasing postprandial rise in blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Thiazolidinediones function and mech of action

A
  • Antidiabetic agents that work primarily by decreasing insulin resistance
  • Decrease insulin resistance by activating a specific receptor type in the cell nucleus known as PPAR gamma, as a result insulin responsive genes are turned on that hep regulate carbohydrate and lipid metabolism, cellular response to insulin is increased promoting uptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Thiazolidinediones ADR’s (4)

A
  • Uncertain if benefits outweigh risks
  • Heart failure
  • weight gain
  • anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Rosiglitazone (avandia) drug class, function and ADR’s (3)

A
  • Thiazolidinediones
  • Approved for monotherapy or with metformin for treatment of type 2 diabetes
  • edema, weight gain, mild anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Pioglitazone (ACTOS) drug class, function, ADR’s (3)

A
  • Thiazolidinedions
  • Approved for monotherapy or with metformin for treatment of diabetes
  • Fractures, bladder cancer, hepatotoxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Metiglinides (Glinides) function

A

Short acting agents for type 2 diabetes with same mech of action as sulfonylureas, tend to be shorter acting tho and are taken with each meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

DPP-4 inhibitors mech of action and therapeutic use (1)

A

Promote glycemic control by enhancing the actions of incretin hormones, potentiating glucose dependent secretion of insulin and suppress glucagon secretion, produce modest reductions in A1C levels when used as monotherapy
-2nd line therapy as add on to metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Sitagliptin (Januvia) drug class, function, and ADR’s (3)

A
  • DDP inhibitor
  • Approved for PO monotherapy or in combo with other antidiabetic drugs for treatment of type 2 diabetes
  • URI, headaches, pancreatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

SGLT2 inhibitors mech of action and other benefit

A
  • Block SGLT2 transporters decreasing renal glucose reabsorption and increasing urinary glucose excretion, reducing fasting and prepreandial blood glucose levels
  • Reduction in SBP reducing CV risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

SGLT2 inhibitors ADR’s (3)

A
  • frequent mycotic genital and urinary tract infection
  • fournier gangrene (necrotizing infection of external genitalia, perineum, and perianal region)
  • acute kidney injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Glucagon like peptide 1 (GLP1) receptor agonists function and mech of action

A
  • injectable agents administered SC for treatment of type 2 diabetes
  • Have same physiologic effect as endogenous incretins slowing gastric emptying stimulation of glucose dependent release of insulin and inhibition of postprandial release of glucagon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

GLP 1 agonist ADR’s (2)

A
  • pancreatitis
    -medullary thyroid cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Pramlintide (symlin) drug class and function

A
  • synthetic analog of human amylin (amylin mimetic)
  • approved for adjunctive treatment for patients with type 1 or 2 diabetes who inject insulin at mealtimes and have failed to achieve glucose control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Lispro (humalog) rapid absorption mech of action

A

-unlike most insulin, avoids self association to form hexamers unlike most insulins and thus attains more rapid absorption and onset of action (15 min)

57
Q

Regular insulin (humulin R) function

A

Unmodified crystalline insulin that is short acting soluble insulin, after SC injection forms small hexamers delaying absorption and onset to .5-1 hour, with peak action occurring 2.5-5 hours, and lasting 4-12 hours

58
Q

Regular U-500 insulin function (Humulin)

A

Normal insulin indicated in patients who require >200 units/day specifically targeting insulin resistant patients with severe type 2 diabetes, exhibits both a bolus and basal effect and can be used as monotherapy in some cases for type 2 diabetics

59
Q

Examples of long acting insulin (3)

A
  • Lantus
  • levemir
  • toujeo
60
Q

Lantus function

A

Long acting peakless insulin analog, mimics basal effects of insulin secreted by healthy pancreas

61
Q

Administration of insulin

A

Must be given by injection or inhalation because it is degraded in the stomach as a peptide

62
Q

Treatment of hypoglycemia in patients (3)

A
  • oral sugar supplements (NOT chocolate or hard piece of candy - aspiration risk if loss of gag reflex or unconscious)
  • IV dextrose
  • Glucagon
63
Q

2 causes of diabetic coma that must be determined

A
  • hypoglycemic requiring withholding of insulin
  • ketoacidosis which requires insulin
64
Q

What is the leading cause of end stage renal disease?

A

Diabetic nephropathy

65
Q

Characteristics of type 1 diabetes (6)

A
  • Autoantibodies presence against B cells of pancreas
  • Absolute insulin deficiency requiring supplementation
  • Most common in youth
  • acute onset
  • Ketosis prone
  • Genetic predisposition
66
Q

Physiological serum insulin secretion profile

A
  • Spikes after each meal before quickly lowering to low poinr (50% of insulin content)
  • In the night time, see drop to low amount but never to zero because of glycogen breakdown and gluconeogenesis from the liver AND kidney** that occur during sleep causes need to keep some insulin up at all times (50% of insulin content)
67
Q

Between meal and overnight (long acting) insulin options (peakless baseline, 1 shot a day) (5)

A
  • levemir
  • lantus
  • tresiba
  • toujeo
  • basaglar

These are incredibly expensive, all made by bacteria and e coli from recombinant human insulin analog modified to be long acting

68
Q

NPH insulin analog function

A

Given once every 12 hours (twice a day) to maintain closest to baseline, but does see a peak about 5-6 hours after administration, very cheap and affordable

69
Q

Quick acting insulin analogue (normal insulin) function

A

-starts working in about half an hour (take about that amount of time before a meal), peaks within 2 hours, and then quickly drops off, concern if taken without a meal following shortly after

70
Q

Immediate acting insulin analogues (3) and function

A
  • aspart, glulisine, lispro
  • Act almost immediately after taking, most closely mimics the body’s insulin, so fast acting can be given after 10-15 min post meal and dosed corresponding to what percent of meal they ate (good to prevent giving before and then they don’t eat and then we are screwed)
71
Q

Typical starting dose for between meal and overnight insulin (long acting)

A

.3 u/kg

72
Q

Advantages of continuous subcutaneous insulin infusion (4) and disadvantages (2)

A
  • Programmable for meals and overnight
  • greater flexibility of lifestyle
  • fewer injections
  • control as good as multiple daily injections if not better
  • risk of ketosis from interruption
  • complexity
73
Q

Should a continuous subQ insulin infusion fail, patient needs to have what waiting at home?

A

-long acting insulin refrigerated (allows patient to get it in case of failure of pump, can then just inject pump manually to simulate for meals)

74
Q

Sliding scale insulin regimens

A

-Chart that allows for blood glucose level to directly determine amount of insulin to be delivered to patient

75
Q

Glycemic control in a hospital patient target range

A

144-180mg/dL

76
Q

Diabetic ketoacidosis treatment options (4)

A
  • restoration of volume
  • correct acidosis (slower to correct than hyperglycemia)
  • replenish K+
  • correction of hyperglycemia
77
Q

Risk factors for type 2 diabetes (1 big one and 6 others)

A
  • first degree relative with DM***
  • age >45
  • obesity
  • sedentary lifestyle
  • hypertension
  • dislipidemia
  • Gestational diabetes history (or large child delivery >9lbs)
78
Q

The ominous octet of type 2 diabetes causes

A
  • Liver overproducing sugar
  • B cells not making enough insulin (exhaustion after making excess in early stages of resistance)
  • a cells making too much glucagon
  • Skeletal muscle not taking up glucose
  • GI tract and incretin effect
  • Neurotransmitter dysfunction in the brain causing hunger
  • Increased glucose reabsorption at the kidney
  • increased lipolysis of fat cells
79
Q

Metformin acts as a insulin ___ allowing the body to utilize its own insulin better

A

sensitizer

80
Q

Metformin should be avoided when GFR is less than…

A

…45ml/min

81
Q

When B cells fail and become ineffective at producing insulin, what happens to sulfonylureas?

A

They lose functionality only facilitate secretion of insulin

82
Q

Meglitinides (name 2 examples) vs sulfonylureas

A

Meglitinides (repaglinide and nateglinide) are rapid onset oral agents for diabetes to stimulate insulin release and short duration taken with each meal and are not sulfa derivatives and are also safe with renal insufficiency, but like sulfonylureas are not effective with B cell failure

83
Q

Pioglitazone function and ADR’s/contraindications (1)

A
  • Insulin sensitizer drug that is also very good at increasing HDL
  • leads to weight gain due to edema (contraindicated in congestive heart failure patients)
84
Q

The incretin effect

A

Refers to how GLP-1 is secreted upon ingestion of food entering the small intestine which enhances insulin secretion from the B cells dependent on the glucose levels as well as decreases excess glucagon (reducing strain on liver) and turns off appetite urges. This prolongs lifespan and health of B cells.
GLP-1 is not or very little secreted in type 2 diabetics, so GLP-1 agonists that tweak the molecule to lengthen its very short half life allow for injection once a week

85
Q

DPP-4 inhibitors work at the incretin system by…

A

…blocking breakdown of patient’s own incretin hormones raising their own GLP-1 levels several fold in type 2 diabetics

86
Q

SGLT2 inhibitors action

A

Typically 100% of glucose is filtered into the nephron, but at the proximal tubule almost all absorbed along Na+ by SGLT2 transporter, can allow for urination out of about 100grams/day of glucose (weight loss and calorie loss as well), this also lowers blood pressure by dragging fluid with because we are losing glucose and sodium, worry is entering diabetic ketoacidosis

87
Q

SGLT2 inhibitors demonstrate reduction in…

A

…Reduction in cardiovascular death, MI, stroke, and all cause mortality in all patients with type 2 diabetes (this is rare and big! Even cardiologists are using this in patients without diabetes, and are also renal protective in patients with type 2 diabetes OVER ACEI’s and ARBs)

88
Q

4 benefits of SGLT2 inhibitors and list the 4 agents

A
  • Diabetes treatment
  • Weight reduction
  • Cardiovascular disease protection
  • Renal protection

-Ivokana, farxiga, jardiance, steglatro

89
Q

Insulin mixtures ending in -lin vs -log

A

Lin corresponds to rapid acting component being regular insulin (works within 30 min), log correspodns to rapid acting component being humalog (acts within 15 min)

90
Q

Hypoglycemia definition

A

Episode of abnormally low plasma glucose conc. that exposes an indiviual to potential harm, considered severe (uncorrectable by self) when <70mg/dL

91
Q

Symptoms of hypoglycemia (7)

A
  • palpitations
  • tremor
  • sweating
  • hunger
  • paresthesia
  • cognitive or behavioral change
  • more than 50% asymptomatic***
92
Q

If a patient is on metformin, sulfonylurea, and SGLT2 all to control diabetes and they have a hypoglycemic episode, the culprit of their reaction and the one to lower is the…

A

….sulfonylurea

93
Q

Hypoglycemia treatment in a patient who can still consume food

A
  • 2-3 glucose tabs
  • 3-5 hard candies
  • etc.
  • Repeat if not improved in 15 minutes
  • follow with meal of bread and protein
94
Q

Medication adjustment for hypoglycemic episode should only be considered when not readily explained by…

A

….conventional factors including skipped or irregular meals or unaccustomed exercise

95
Q

Neovascularization of the retina

A

The body’s response to lack of adequate blood flow due to hypoglycemia to the retina by making new vessels that are very fragile and can leak exudates blocking vision

96
Q

Metabolic memory/legacy effect

A

Refers to how patients who have early aggressive management of diabetes have better outcomes and less progression in retinopathy, neuropathy, and nephropathy than those who did not even after returning to less intense therapy later on

97
Q

Diabetic retinopathy treatment (2)

A
  • Panretinal laser photocoagulation decreases loss in patients
  • Focal laser photocoagulation in eyes decreases loss in patients
98
Q

Earliest marker of diabetic nephropathy we should test for in at risk groups for diabetes progression

A

Microalbuminuria (more predictive as can detect lower levels than a dipstick and progression is likelty to result in end stage renal disease)

99
Q

Diabetic nephropathy albuminuria requires ___ abnormal specimens over __ time period to make diagnosis

A

2-3, 3-6 months

100
Q

Even in the absence of hypertension, if a patient has presence of micro or macroalbumin they should be placed on…

A

….an ACEI or ARB (never both just FYI)

101
Q

Recall, ACEI and ARB’s dilate what vessel of the renal system?

A

Efferent arteriole

102
Q

SGLT2 inhibitors constrict what vessel of the renal system?

A

Afferent arterioles

103
Q

Common presentation of diabetic peripheral neuropathy

A

Chronic, symmetrical**, length dependent (feet before hands) sensation then motor polyneuropathy with nocturnal exacerbation making prickly pain worse

104
Q

Thyroid disease epidemiology

A
  • Most autoimmune
  • Women>men
  • Familial predisposition
  • Radiation exposure risk
105
Q

Drug effects on the thyroid

A
  • Estrogen therapy increases thyroid binding and thus may require increased dosing of thyroid hormone to maintain free hormone levels
  • Biotin in popular supplements can interfere with lab testing (hold 48 hrs before testing)
  • supplements such as antacids can prevent absorption of thyroid hormone
106
Q

Differential for hyperthyroidism causes (5)

A
  • Graves disease
  • Toxic multinodular goiter
  • Toxic adenoma
  • Subacute thyroiditis
  • Iatrogenic origin
107
Q

Common presentation of hyperthyroidism (4)

A
  • Sweating, tremor, palpitations
  • widened pulse pressure and tachycardia
  • proximal muscle weakness
  • lid lag
108
Q

Graves disease

A

Most common hyperthyroid disease onset of 20-50 years of age where an individual has developed autoantibodies for the TSH receptor at the thyroid causing excessive thyroid activity

109
Q

Graves opthalmopathy

A

Immunologic mediated accumulation of extracellular water and ground substance that only occurs in about 20% of patients with graves disease unless they smoke which greatly increases risk, can result in diplopia or vision loss (optic nerve can stretch out causing everything to get green hue)

110
Q

Lab results (TSH, free T3/4, thyrotropin receptor antibody test) in Graves disease

A
  • TSH low
  • T3/4 elevated
  • Positive thyrotropin receptor antibody test
111
Q

Hyperthyroidism from Graves disease treatment options (5) and ADR (1)

A
  • Antithyroid drugs tapazole and PTU (block production of thyroid hormone), B blockers to control side effects, irradiation therapy, surgery
  • Agranulocytosis (leukopenia)
112
Q

Why is tapazole preferred to PTU for treatment of hyperthyroidism?

A

-It is not as hepatotoxic, but preference is reversed in pregnancy

113
Q

Subacute thyroiditis progression

A
  • Initial phase of hyperthyroidism from healthy stores of thyroid hormone being released due to viral mediation
  • Later transient phase of hypothyroidism
  • Total resolution by 2-3 months
114
Q

Subacute thyroiditis treatment options (4)

A
  • Analgesics/NSAIDs
  • B blocker in hyperthyroid phase
  • thyroid hormone if hypothyroid phase
  • Self limiting and does not return
115
Q

Presentation of new onset of afib in elderly indicates need for…

A

….thyroid studies

116
Q

Peroxidase antibody

A

Test for hypothyroidism, if positive usually indicates hashimoto’s hypothyroidism

117
Q

Hypothyroidism treatment options (1)

A

-Synthroid (L thyroxine)

118
Q

Amiodarone and thyroid function

A

Can cause toxic effect on thyroid cell due to high iodine content, usually in a patient with underling hashimoto’s hypothyroidism and thus has the same signs and symptoms or hyperthyroidism either type I (excess iodine) or type II (destructive thyroiditis)

119
Q

Lithium and thyroid function and treatment (1)

A

Taken up by thyroid cells but cannot be utilized and thus inhibits formation and secretion of T3/4, changes in patients with underlying hashimoto’s hypothyroidism (goiter, fatigue), treated with supplemental synthroid

120
Q

Postpartum thyroiditis

A

Presents like hyperthyroidism in the setting of postpartum approx 4-7% of population due to inflammation causing same course as subacute thyroiditis (hyperthyroid phase that is severe and looks like graves but lacks thyroid stimulating immunoglobin levels and gets better with time followed by hypothyroid phase)

121
Q

Postpartum thyroiditis treatment options (3)

A
  • Self limiting and recurs with future pregnancy***
  • B blockers for hyperthyroid phase
  • Thyroid replacement for hypothyroid phase
122
Q

Hyperthyroidism treatment of choice in pregnant woman with graves disease

A

-PTU (does cross placenta, need to give lowest amount to keep mother’s levels normal)

123
Q

Thyroid cancer frequency, diagnostic tests (2)

A

-only 5% of nodules are cancer (relatively rare), ultrasound determine solid vs cyst and size (<1cm no clinical significance) and regular border no concern or fine needle aspiration

124
Q

Hot vs cold nodules (thyroid scan)

A

Hot have high radiologic activity and cold do not, cold are more concerning for cancer

125
Q

Most common type of thyroid cancer and management (5)

A
  • Papillary
  • Resection of gland, iodine ablation, thyroid hormone replacement, whole body scan, serum thyroglobulin (only present if not all thyroid tissue was removed)
126
Q

Sick euthyroid syndrome

A

Acute or chronic non-thyroidal illness that is often seen with decreased T3/4 with normal TSH and has no thyroid treatment necessary

127
Q

Role of parathyroid hormone

A

Maintain extracellular fluid ca2+ balance, acts directly on bone and kidney, acts indirectly on gut thru vit d production

128
Q

Differential for hypercalcemia (6)

A
  • PTH related
  • Malignancy
  • Vit D intoxication
  • Hyperthyroidism
  • thiazide diuretics
  • Excessive alkaline agent ingestion
129
Q

Hypercalcemia clinical features (4)

A
  • asymptomatic
  • fatigue, depression
  • N/V
  • stone formation
130
Q

Primary hyperparathyroidism

A

Inappropriate elevation of PTH levels in relation to elevated Ca2+ levels, most often caused by a solitary adenoma

131
Q

Treatment indications for primary hyperparathyroidism in asymptomatic patients (4)

A
  • Only if serum Ca2+ >1.0mg/dL above normal
  • or if osteoporosis development
  • or if age less than 50
  • or if kidney impairment
132
Q

Treatment for primary hyperparathyroidism first choice and backup option

A
  • Surgical removal using intraoperative rapid PTH assays between removing one parathyroid gland or in the case of 4 gland hyperplasia remove 3.5 glands and autotransplant remnant into forearm
  • Cinacalcet (sensipar) that is a calcimimetic agent that lowers PTH levels
133
Q

Chvostek sign

A

Light tap on facial nerve sees corner of mouth twitch in response, common in normal individuals but bilateral can indicate hypocalcemia

134
Q

Trousseau’s sign

A

Pump blood pressure cuff above systolic and retain it until the patient cramps up due to acidosis, indicative of hypocalcemia

135
Q

Differential for hypocalcemia (4)

A
  • chronic renal failure
  • hypoparathyroidism
  • vit D deficiency
  • transient
136
Q

Hypocalcemia signs and symptoms (3)

A
  • muscle spasms, convulsions
  • mental status change
  • positive chvostek and trousseau sign
137
Q

Vit D action

A

Increases intestinal ca2+ absorption and increases effect of PTH on the bone, sourced from sunlight or from fortified foods, converted to active form at liver and kidney and acts on gut

138
Q

Common causes of vit D deficiency (3)

A
  • GI malabsorption
  • Cirrhosis or kidney failure
  • steroids/anticonvulsants
139
Q

Vitamin D replacement therapy

A

Vit D3 50,000 IU weekly for 4-6 weeks, then maintenance 800-2000 IU daily

Professional Development (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions